202 related articles for article (PubMed ID: 14560137)
1. Renal cell carcinoma: novel treatments for advanced disease.
Huland E; Heinzer H
Curr Opin Urol; 2003 Nov; 13(6):451-6. PubMed ID: 14560137
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient].
Heinzer H; Huland E; Huland H
Urologe A; 2003 Nov; 42(11):1450-2. PubMed ID: 14624342
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell cancer treatments.
Sternberg CN
Drugs Today (Barc); 2003; 39 Suppl C():39-59. PubMed ID: 14988745
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for renal cell carcinoma.
Rosenblatt J; McDermott DF
Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in renal cell cancer immunotherapy.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
[TBL] [Abstract][Full Text] [Related]
6. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
7. Novel treatment strategies in clear-cell metastatic renal cell carcinoma.
van Spronsen DJ; de Weijer KJ; Mulders PF; De Mulder PH
Anticancer Drugs; 2005 Aug; 16(7):709-17. PubMed ID: 16027518
[TBL] [Abstract][Full Text] [Related]
8. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
Thomas JS; Kabbinavar F
Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma - innovative medical treatments.
Huland E; Heinzer H
Curr Opin Urol; 2004 Jul; 14(4):239-44. PubMed ID: 15205581
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of metastatic renal cell cancer.
Fishman M; Seigne J
Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
[TBL] [Abstract][Full Text] [Related]
11. New immunotherapy in the treatment of advanced renal cancer.
Muto A; Gridelli C
Expert Opin Emerg Drugs; 2019 Dec; 24(4):233-237. PubMed ID: 31751164
[No Abstract] [Full Text] [Related]
12. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy for advanced renal cell carcinoma].
Aulitzky WE; Kaufmann M
Urologe A; 2004 Jan; 43(1):85-92; quiz 93. PubMed ID: 15179984
[TBL] [Abstract][Full Text] [Related]
14. IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.
Rausch S; Kruck S; Stenzl A; Bedke J
Future Oncol; 2014 May; 10(6):937-48. PubMed ID: 24941980
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of metastatic renal cell carcinoma.
McDermott DF
Cancer; 2009 May; 115(10 Suppl):2298-305. PubMed ID: 19402060
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
Pantuck AJ; Belldegrun AS; Figlin RA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
Guida M; Colucci G
Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy of metastatic renal cell carcinoma. Is clinical use justified in view of outcome, side effects and costs?].
Oberneder R; Kriegmair M; Staehler M; Hofstetter A
Urologe A; 1997 Mar; 36(2):130-7. PubMed ID: 9199040
[TBL] [Abstract][Full Text] [Related]
19. [Cytokine therapy of metastatic renal cell carcinoma].
Otto T; Goepel M; Luboldt HJ; RĂ¼bben H
Urologe A; 1995 May; 34(3):200-3. PubMed ID: 7610512
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]